Socio-demographic data | N (%) |
Age at death (years) | |
< 60 | 417 (11.4) |
[60–70] | 623 (17.0) |
[70–80] | 1150 (31.4) |
≥ 80 | 1468 (40.1) |
Sex | |
Male | 2037 (55.7) |
Female | 1621 (44.3) |
Year of death | |
2017 | 1813 (49. 6) |
2018 | 1845 (50.4) |
Social area living | |
Socially advantaged | 1608 (44.0) |
Socially disadvantaged | 2001 (54.7) |
Missing data | 49 (1.3) |
Clinical Data | N (%) |
Type of leukemia | |
Acute myeloid leukemia | 3426 (93.7) |
Acute promyelocytic leukemia | 20 (0.6) |
Acute myelomonocytic leukemia | 170 (4.7) |
AML with 11q23 | 19 (0.5) |
AML with dysplasia of several cell lines | 161 (4.4) |
Acute monoblastic/monocytic leukemia | 123 (3.4) |
Acute pan myelosis with myelofibrosis | 72 (2.0) |
Megakaryocyte leukemia | 22 (0.6) |
Acute erythroid leukemia | 31 (0.9) |
Acute lymphoid leukemia | 231 (6.3) |
Months between diagnosis and death | |
≤ 3 | 703 (19.2) |
[3–12] | 806 (22.0) |
[12–36] | 1084 (29.6) |
> 36 | 1065 (29.1) |
Allogeneic stem cell transplantation | |
No | 3394 (92.8) |
Yes | 264 (7.2) |
Charlson score (co-morbidities) a | |
0 | 1459 (39.9) |
1–2 | 1411 (38.6) |
≥ 3 | 788 (21.5) |
Last hospitalization stay | N (%) |
Type of hospital c | |
Non-specialized hospital | 2245 (61.4) |
Specialized hospital | 1413 (38.6) |
Death in an intensive care structure | 495 (13.5) |
Palliative care structure in the last 3 days of life b | 745 (20,4) |
Time in a palliative care structure before death | |
≤ 1 month | 2545 (69.6) |
> 1 month | 1113 (30.4) |
Travel time from patients’ home (minutes) | |
≤ 10 | 1047 (28.6) |
[10–30] | 1071 (29.3) |
[30–60] | 652 (17.8) |
> 60 | 945 (21.8) |
Length of stay (days) | |
≤ 15 | 1382 (37.8) |
[15–30] | 1361 (37.2) |
> 30 | 929 (25.0) |